Coffee May Be Unexpected Protectant Against COVID-19 Infection
Drug Topics
NOVEMBER 20, 2023
Rich in polyphenolic compounds like chlorogenic acid (CGA), coffee may help ward off COVID-19 infection in the post-pandemic era.
Mon.Nov 20, 2023
467 
Biohaven wants to muscle in on the Ozempic craze with a competing class of drugs
PharmaVoice
NOVEMBER 20, 2023
Biohaven and other companies are aiming to develop meds with a different mechanism of action that trim the waistline while building lean tissue.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
First At-Home Test for Chlamydia, Gonorrhea Approved by FDA
Drug Topics
NOVEMBER 20, 2023
The FDA approval marks an important public health milestone in the ongoing effort to empower patients to take control of their own health.
Telemedicine Shows Increase in Curing Hepatitis C Virus Related to Opioid Use Disorder
Pharmacy Times
NOVEMBER 20, 2023
The results suggest that telemedicine could be used to help improve access for other populations that might be stigmatized, beyond hepatitis C virus and opioid use disorder.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacists Must Join Advocacy Efforts to Help Move the Profession Forward
Drug Topics
NOVEMBER 20, 2023
Drug Topics recently sat down with Steve Hoffart, PharmD, owner and PIC at Magnolia Pharmacy north of Houston, to discuss the importance of pharmacists getting involved in advocacy.
Respiratory viruses, thrown out of whack by Covid, appear to be falling back into seasonal order
STAT
NOVEMBER 20, 2023
In the depths of the Covid-19 pandemic, something strange happened: For a year or two, illnesses that used to emerge like clockwork when fall and winter arrived — flu, RSV, and the myriad viruses that cause colds — did not sicken us. The cause now appears clear: The measures we took to avoid the new disease, including isolating and social distancing, muscled most other respiratory pathogens out of the cold-and-flu-season picture.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Opinion: The FDA is at a crossroads on cell and gene therapies
STAT
NOVEMBER 20, 2023
Cell and gene therapies are the next frontier in medicine and promise long-sought hope for people living with incurable and fatal conditions. As their promise increasingly becomes reality, the FDA’s gatekeeping role is important. To truly serve the people who need these medications, the FDA must be a good-faith partner and deploy the tools my fellow congressional lawmakers and I helped secure.
Vitamin B5 May Be Associated with Tumor Growth In Certain Types of Cancer Cells
Pharmacy Times
NOVEMBER 20, 2023
Mice with human breast cancer tissue and high levels of the Myc cancer-driving gene who received a vitamin B5-deficient diet had slower tumor growth.
STAT+: How a major hospital shows just how inflated hospital list prices are
STAT
NOVEMBER 20, 2023
Hospitals’ list prices for surgeries, therapies, and other procedures always come with massive discounts. Financial documents at a prominent hospital system in Los Angeles show just how large those discounts are — and how raw of a deal uninsured patients could be getting. Cedars-Sinai reported more than $10.2 billion of gross patient revenue in the most recent three-month period that ended Sept. 30, according to new financial documents.
AB-1002 Demonstrates Improvements for Congestive Heart Failure in First-in-Human Study
Pharmacy Times
NOVEMBER 20, 2023
Improvements were seen in left ventricular ejection fraction, NYHA Functional Class, and Minnesota Living with Heart Failure Questionnaire at 1-year post-dose.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: Hospitals put tech spending on a tight leash, raise the bar for pilots
STAT
NOVEMBER 20, 2023
Health systems whose budgets were squeezed dry during the pandemic are creeping back into the black, but they’re far from the days when they had cash to blow on flashy tech pilots that might never pan out. Instead, hospital leaders are increasingly cautious about their spending and the technology they test out, insisting that new products demonstrate concrete, measurable benefits to patients without disrupting an already fatigued clinical workforce — a marked difference from the pr
Patients With Melanoma, Clinicians Report Telehealth Consultations Are Beneficial When Combined With In-Person Care
Pharmacy Times
NOVEMBER 20, 2023
Despite patients and clinicians preferring in-person consultations, most patients reported that clinicians answered all questions and effectively resolved issues during remote consultations.
STAT+: What Eli Lilly’s Zepbound reveals about the intricate process of naming drugs today
STAT
NOVEMBER 20, 2023
Whether you’re a fan of the drug name Zepbound or, like one X user , think it sounds like “an off brand bus line,” you’re likely to have some opinion about the new moniker for Eli Lilly’s blockbuster diabetes drug Mounjaro. The company announced the new name on Nov. 8 following the Food and Drug Administration’s approval of the drug for weight loss as well.
Medicare paid out $31.2B in improper payments for FY23, CMS says
Fierce Healthcare
NOVEMBER 20, 2023
Traditional Medicare paid out an estimated $31.2 billion in improper payments in fiscal year 2023, according to new data from the federal government. | The Centers for Medicare & Medicaid Services released its annual look at improper payments and found that the overall rate in Medicare was 7.38%, which sits below the 10% level mandated in statute.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Failure to Contact Patient Leads to Severe Health Consequences, Lawsuit
Pharmacy Times
NOVEMBER 20, 2023
Patient sues pharmacy citing communication gaps after prescription was located
STAT+: U.K., pharma industry strike deal for how the NHS pays for medicines
STAT
NOVEMBER 20, 2023
LONDON — The U.K. and the pharmaceutical industry have reached a deal on a five-year plan outlining how the health system pays for drugs, as the country tries to keep a lid on its medicines spending while simultaneously building up its life sciences industry. The plan, which goes into effect next year, was announced Monday in a joint statement from the government, England’s National Health Service, and the Association of the British Pharmaceutical Industry.
Minimizing Terms in Multiple Myeloma Clinical Trials May Inaccurately Reflect Tolerability, Rates of AEs
Pharmacy Times
NOVEMBER 20, 2023
The study authors suggest that future research should instead emphasize event rates and patient-reported outcomes to better evaluate the tolerability and frequency of AEs.
NICE to consult on inflation-busting fee increases
pharmaphorum
NOVEMBER 20, 2023
NICE to consult on inflation-busting fee increases Mike.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
How to choose a nasal spray for allergies
The Checkup by Singlecare
NOVEMBER 20, 2023
Seasonal allergies are commonly associated with spring, but summer and fall can also trigger allergy symptoms. Also known as hay fever or allergic rhinitis, seasonal allergies can cause symptoms like sneezing, a runny nose, and itchy, watery eyes. No matter how often your allergies flare up, you don’t have to live with the symptoms as there are many effective treatments, including eye drops, shots, and oral medications.
Supply chains and the importance of transparency
pharmaphorum
NOVEMBER 20, 2023
Supply chains and the importance of transparency Mike.
STAT+: Pharmalittle: CRISPR pioneers reflect on future of gene editing; U.K. and pharma reach deal on how NHS pays for drugs
STAT
NOVEMBER 20, 2023
Good morning and welcome to Thanksgiving week! STAT reporter Andrew Joseph here filling in for Mr. Pharmalot today. It’s my first Thanksgiving since moving over to London to expand STAT’s European coverage, but never fear, a Thanksgiving feast will be had on Thursday. (A reminder: It’s not too early to get started on some prep. I made my pie crusts over the weekend and they will hang in the freezer for a few days.
Empathy: The missing link in HCP-pharma relationships?
pharmaphorum
NOVEMBER 20, 2023
Empathy: The missing link in HCP-pharma relationships? Mike.
Takeda wins EU approval for paediatric use of Takhzyro in HAE
Pharmaceutical Technology
NOVEMBER 20, 2023
Takhzyro has been approved for the routine prevention of recurrent hereditary angioedema attacks in patients aged 2 years and older.
Eversana taps Adobe Firefly in quest to ‘pharmatise’ genAI
pharmaphorum
NOVEMBER 20, 2023
Eversana taps Adobe Firefly in quest to ‘pharmatise’ genAI Phil.
After protests, pharma industry reaches 'landmark' drug spending deal with UK government
Fierce Pharma
NOVEMBER 20, 2023
After blasting the U.K.’s drug pricing policy, the pharma industry has secured a new government spending deal featuring a higher revenue cap and an innovative drug-friendly rebate mechanism. | After blasting the U.K.’s drug pricing policy, the pharma industry has secured an improved government spending deal. The agreement will double the annual growth rate for prescription meds over the coming years.
'Landmark' deal reached on UK voluntary rebate scheme
pharmaphorum
NOVEMBER 20, 2023
'Landmark' deal reached on UK voluntary rebate scheme Phil.
How to get rid of a hangover headache
The Checkup by Singlecare
NOVEMBER 20, 2023
Most of us have been there, but it’s still no fun to wake up with our heads throbbing after a big night out. Hangovers, one symptom of which is headaches, are caused and exacerbated by a handful of factors associated with excessive alcohol consumption. A 2015 study published in the Experimental and Clinical Psychopharmacology journal found that hangovers affect 75% of the general population after moderate alcohol consumption.
Bayer pulls atrial fibrillation study for asundexian
pharmaphorum
NOVEMBER 20, 2023
Bayer pulls atrial fibrillation study for asundexian Phil.
Merck cough drug doesn’t pass panel scrutiny
STAT
NOVEMBER 20, 2023
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we explore the future of obesity drugs and how they’re named, we chat with CRISPR pioneers about what it’s like to see the technology approved for human use, and more.
AZ launches digital clinical trials business
pharmaphorum
NOVEMBER 20, 2023
AZ launches digital clinical trials business Phil.
AstraZeneca launches new digital health solutions business Evinova
Pharmaceutical Technology
NOVEMBER 20, 2023
AstraZeneca has launched a new digital health solutions business, Evinova, to expedite innovation in the life sciences industry.
After FDA no, Almirall’s eczema drug gets EU okay
pharmaphorum
NOVEMBER 20, 2023
The European Commission has approved Almirall’s lebrikizumab as Ebglyss for the treatment of moderate-to-severe atopic dermatitis (AD), with an EU rollout set to start in Germany next year.
Are haemophilia gene therapies truly “one and done”?
Pharmaceutical Technology
NOVEMBER 20, 2023
The value of haemophilia gene therapies like Roctavian and Hemgenix hinge on long-term efficacy and innovative payment structures play a key role.
Let's personalize your content